Comerica Bank Biocryst Pharmaceuticals Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Comerica Bank holds 148 shares of BCRX stock, worth $1,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares

148

Previous 13,648 98.92%

Holding current value

$1,075

Previous $84,000 98.81%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.41 - $8.69 $86,535 - $117,315	-13,500 Reduced 98.92%	148 $1,000
Q2 2024 Aug 15, 2024	SELL	$4.13 - $6.79 $55,755 - $91,665	-13,500 Reduced 49.73%	13,648 $84,000
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $264 - $413	54 Added 0.2%	27,148 $137,000
Q3 2023 Nov 21, 2023	BUY	$6.71 - $7.92 $181,800 - $214,584	27,094 New	27,094 $191,000
Q2 2022 Aug 02, 2022	BUY	$7.89 - $17.88 $2,406 - $5,453	305 Added 2.26%	13,805 $164,000
Q3 2021 Nov 22, 2021	SELL	$14.21 - $17.65 $69,955 - $86,890	-4,923 Reduced 26.72%	13,500 $193,000
Q2 2021 Aug 26, 2021	SELL	$9.5 - $17.24 $4,123 - $7,482	-434 Reduced 2.3%	18,423 $291,000
Q1 2021 Apr 28, 2021	SELL	$7.37 - $13.61 $4,893 - $9,037	-664 Reduced 3.4%	18,857 $191,000
Q4 2020 Jan 28, 2021	SELL	$3.37 - $8.61 $1,297 - $3,314	-385 Reduced 1.93%	19,521 $145,000
Q3 2020 Oct 30, 2020	BUY	$3.43 - $5.53 $2,164 - $3,489	631 Added 3.27%	19,906 $68,000
Q2 2020 Jul 31, 2020	BUY	$1.9 - $5.61 $1,968 - $5,811	1,036 Added 5.68%	19,275 $91,000
Q4 2019 Feb 07, 2020	BUY	$1.59 - $3.45 $2,119 - $4,598	1,333 Added 7.88%	18,239 $62,000
Q3 2019 Oct 31, 2019	SELL	$2.5 - $3.73 $132 - $197	-53 Reduced 0.31%	16,906 $48,000
Q4 2017 Feb 02, 2018	BUY	$4.16 - $5.33 $2,238 - $2,867	538 Added 3.28%	16,959 $83,000
Q3 2017 Nov 06, 2017	BUY	$4.1 - $5.97 $67,326 - $98,033	16,421	16,421 $73,000

Others Institutions Holding BCRX

# of Institutions

280

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.35B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account